<- Go Home
Vetoquinol SA
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, pigs, dogs, and cats. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Market Cap
EUR 861.1M
Volume
4.0K
Cash and Equivalents
EUR 181.5M
EBITDA
EUR 102.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 308.2M
Profit Margin
57.89%
52 Week High
EUR 96.00
52 Week Low
EUR 63.60
Dividend
N/A
Price / Book Value
1.51
Price / Earnings
14.32
Price / Tangible Book Value
2.38
Enterprise Value
EUR 697.4M
Enterprise Value / EBITDA
6.41
Operating Income
EUR 78.4M
Return on Equity
10.79%
Return on Assets
6.84
Cash and Short Term Investments
EUR 181.5M
Debt
EUR 17.7M
Equity
EUR 567.5M
Revenue
EUR 532.4M
Unlevered FCF
EUR 44.3M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium